I welcome the fact that this debate is happening in Government time, and I was delighted to support the Back-Bench application for it. It is also a pleasure to follow Jim Dowd. I congratulate Sarah Olney in her absence. Had she been here, I would have gently pointed out that Richard III is a rather popular monarch in Leicestershire and has been rather good for our tourist industry.
This debate is important to my constituency, which has Loughborough University at its heart, to my constituents and to our potential life science opportunity zone at Charnwood Campus. It is a shame that the Minister for Universities, Science, Research and Innovation is not still in his place, because I had hoped that he might have given us an early Christmas present by announcing life science opportunity zone status for the Charnwood Campus. Perhaps the Parliamentary Under-Secretary of State for Exiting the European Union will make a note of that, although I do not expect him to make such an announcement this evening. I must also mention the other businesses and organisations in my local area that rely on science and research, including the University of Leicester. The Science Minister recently visited Loughborough, so he will know that, according to the 2014 research excellence framework, 65% of Loughborough’s academic staff are involved in internationally-leading research, putting the university 17th out of 154 higher education institutions. It ranks 10th in England for research intensity and generates in excess of £40 million a year in research grants. That experience is directly relevant to the university’s concerns about EU funding and collaboration.
It is right to recognise the commitment of this Government and previous Governments to science and research funding. I pay tribute to the Science Minister—he is now back in his place and if he has not heard from his fellow Minister about my request for an early Christmas present, I suggest he ask now—to my hon. Friend George Freeman and the previous Member for Havant, who now resides in the other place, for fighting the science corner in successive Budgets, autumn statements and spending rounds. The Government are delivering on their manifesto commitment to protect the science capital budget, and the science budget of £4.7 billion will rise in cash terms every year in this Parliament.
It is fair to say that science and research funding was perhaps not at the forefront of the campaigning or in the general hubbub around
“Being in the EU puts us in a much larger market than UK alone. It helps to attract and employ the best people to compete in fierce international markets. The UK should be seen as modern, open and inclusive to invite further investment.”
Some on the Government Benches will disagree about the terms on which we conclude Brexit, but we can agree, based on figures already cited, that UK research is enormously influential around the world. What was missing from the discussion before
Advances in research and the consequent benefits to society and the economy could not be realised simply by having the same level of funding go through a UK funding body. Loughborough University tells me that urgent action is required to guarantee UK participation in EU research networks post-Brexit, including continuing to contribute to funding of EU research programmes initiated during the two years after invoking article 50. We will all have anecdotes about research bids in which the UK has been dropped completely as a participant or co-ordinator due to the referendum, but I know of at least one case in which the UK institution was invited back into the project following the Treasury statement in August on underwriting UK participation, which demonstrates how important that announcement was and how important continuing announcements in the same vein will be. I welcome the Chancellor having given that commitment. We have already heard demands that the UK have associated country status in Horizon 2020—third country status would be much less satisfactory.
A non-university example is Medilink East Midlands, which has supported over 1,000 companies in the development of innovations through the European regional development fund project that it ran between 2008 and 2015. It has three new ERDF projects that will continue that support for the next couple of years, and it is worth noting that ERDF has been the only source of funding for business and innovation projects available to them since 2010. Over the past seven years, Medilink EM has delivered an intensive programme of innovation support to the east midlands life sciences sector. In addition to supporting over 1,000 companies, that has meant producing gross value added of over £8.2 million, creating or safeguarding 480 jobs, and helping over 25 new product launches. As we also heard, however, none of this is possible without talking about people, and this is top of the worry list for those most affected by this debate. We have already heard about how much money international students bring—£11 billion to the UK economy each year— but they also make an important cultural contribution. In 2012-13, 5.5% of students studying in the UK were from EU countries, generating £3.7 billion for the UK economy and sustaining 34,000 jobs in local communities. As a local Member of Parliament representing a large university, I can tell the House that those are not always high-value jobs; we are also talking about the cleaners, cooks and administrators who make a university function, leaving aside the other jobs created locally which rely on the university, such as those in retail and leisure. I echo the call of my hon. Friend Ben Howlett that students should not be taken into account in net migration numbers. I welcome the Prime Minister’s statement at last week’s EU Council meeting that she wants an early deal on the rights of EU citizens, and I shall continue to push Ministers to honour that.
In the short time available, I just wish to say that by 2019 we are going to have new immigration and trading policies, and we look forward to a new industrial strategy, and we must have a new relationship that enables our institutions to take part in EU funding for science and research.